Reliq Health Technologies, Inc. Announces New Contract, Expansion into Clinical Trials Market
March 24 2022 - 03:01AM
Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or
WKN:A2AJTB) (“
Reliq” or the
“
Company”), a rapidly growing global healthcare
technology company that develops innovative Virtual Care solutions
for the multi-billion dollar Healthcare market, today announced
that it has signed an agreement with a US Contract Research
Organization to use its iUGO Care software and Patient Engagement
services to support their oncology clinical trials.
“We are very excited to be moving into the
clinical trials space,” said Dr. Lisa Crossley, CEO at Reliq Health
Technologies, Inc. “The oncology clinical trial market alone is
value at over $10 billion USD and is growing at over 5% per year.
Using our iUGO Care platform and Patient Engagement services,
Contract Research Organizations (CROs) can monitor trial-specific
metrics such as medication adherence, side effects/safety and
efficacy, and can also monitor existing comorbidities that must be
tightly controlled during clinical trials such as hypertension,
diabetes and other chronic conditions. We are very pleased to be
working with our new client, a highly respected and experienced CRO
that in the last year alone conducted over 1,000 clinical trials
involving over 200,000 physicians and more than 600 clinical sites.
We will be utilizing a combination of our proprietary solutions for
the clinical trials, including iUGO Care, iUGO Home, iUGO Voice and
the MiUGO patient portal. This contract is expected to generate
recurring revenue of approximately $40 per patient per month. The
Company expects to onboard over 3,000 clinical trials patients in
2022 through this contract.”
Reliq Health
Reliq Health Technologies is a rapidly growing
global healthcare technology company that specializes in developing
innovative Virtual Care solutions for the multi-billion dollar
Healthcare market. Reliq’s powerful iUGO Care platform supports
care coordination and community-based virtual healthcare. iUGO Care
allows complex patients to receive high quality care at home,
improving health outcomes, enhancing quality of life for patients
and families and reducing the cost of care delivery. iUGO Care
provides real-time access to remote patient monitoring data,
allowing for timely interventions by the care team to prevent
costly hospital readmissions and ER visits. Reliq Health
Technologies trades on the TSX Venture under the symbol RHT, on the
OTC as RQHTF and on the WKN as A2AJTB.
ON BEHALF OF THE BOARD“Dr. Lisa Crossley”CEO and Director
For further information please contact:
Company ContactInvestor Relations at
ir@reliqhealth.com
US Investor Relations ContactInvestor
RelationsLytham Partners, LLCBen ShamsianNew York |
Phoenix646-829-9701shamsian@lythampartners.com
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward
Looking Information
Certain statements in this press release
constitute forward-looking statements, within the meaning of
applicable securities laws. All statements that are not historical
facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives,
assumptions, expectations or beliefs of future performance, are
"forward-looking statements".
We caution you that such "forward-looking
statements" involve known and unknown risks and uncertainties that
could cause actual and future events to differ materially from
those anticipated in such statements.
Forward-looking statements include, but are not
limited to, statements with respect to commercial operations,
including technology development, anticipated revenues, projected
size of market, and other information that is based on forecasts of
future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the
"Company") does not intend and does not assume any
obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology
development and marketing activities, the Company's historical
experience with technology development, uninsured risks. Actual
results may differ materially from those expressed or implied by
such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Reliq Health Technologies (TSXV:RHT)
Historical Stock Chart
From Feb 2024 to Mar 2024
Reliq Health Technologies (TSXV:RHT)
Historical Stock Chart
From Mar 2023 to Mar 2024